|4Feb 14, 5:55 PM ET

Clifton R. LaDuane 4

4 · ZEVRA THERAPEUTICS, INC. · Filed Feb 14, 2025

Insider Transaction Report

Form 4
Period: 2025-02-13
Transactions
  • Sale

    Common Stock

    2025-02-13$7.86/sh11,000$86,47151,361 total
Footnotes (1)
  • [F1]Adoption date of referenced 10b5-1(c) plan is: 10/15/2024

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4